Jeff Shaner Sells 90,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 90,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $1,035,000.00. Following the completion of the transaction, the chief executive officer owned 2,561,972 shares in the company, valued at $29,462,678. This represents a 3.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Aveanna Healthcare Stock Down 0.8%

Shares of NASDAQ:AVAH opened at $13.59 on Wednesday. The business’s 50 day moving average is $9.83 and its 200 day moving average is $7.99. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.98. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of 11.05, a PEG ratio of 0.96 and a beta of 1.90. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. On average, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently bought and sold shares of AVAH. BlackRock Inc. bought a new position in Aveanna Healthcare during the second quarter valued at $63,504,000. Vanguard Group Inc. increased its position in Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares during the last quarter. Millennium Management LLC increased its position in Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after buying an additional 1,014,030 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Aveanna Healthcare in the second quarter valued at $7,881,000. Finally, Nuveen LLC raised its stake in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after buying an additional 905,316 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare News Roundup

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target to $16 from $10 and upgraded AVAH to “outperform.” The upgrade reinforces the bullish outlook following the stock’s recent rally. Benzinga analyst coverage
• Positive Sentiment: Truist Financial increased its price target to $15 from $11, although it maintained a “hold” rating. Other analysts have also raised targets after Aveanna exceeded quarterly earnings and revenue expectations. Benzinga analyst coverage
• Positive Sentiment: Aveanna reported quarterly EPS of $0.22 versus the $0.17 consensus estimate and revenue of $670.48 million versus expectations of $638.61 million. The earnings beat supports the improved analyst outlook and investor interest in the shares.
• Neutral Sentiment: Management will participate in the Jefferies Healthcare Services and Technology Conference on September 15. The presentation and one-on-one investor meetings could provide additional business updates, but the event is not an immediate financial catalyst. Aveanna conference announcement
• Negative Sentiment: Major shareholders, including Bain Capital- and J.H. Whitney-affiliated holders, disclosed substantial sales in a roughly $176 million offering. Additional sales by CEO Jeff Shaner, director Rodney Windley, and insider Edwin Reisz at $11.50 per share could weigh on sentiment and increase concerns about selling pressure, even though these holders retained sizable positions. Home Health Care News offering report

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on AVAH shares. Truist Financial boosted their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday. Royal Bank Of Canada increased their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday. UBS Group lifted their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday, August 14th. BMO Capital Markets boosted their price objective on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.89.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.